Amgen Hit by Cyber Incident Involving Patient Data Theft

Amgen Inc., a California-based drugmaker, has disclosed a cyber incident involving the theft of patient information and proprietary data from its cloud servers. The company detected unauthorized access to the data in July but confirmed that some sensitive information had been exfiltrated by mid-August.

The affected data includes patient protected health information, which is considered highly sensitive. Amgen stated that it has not identified any significant impact on its products, manufacturing operations, or financial reporting systems as a result of the breach.

However, the company emphasized that the incident's materiality stems from the volume of files compromised and the potential risk to patient data security. An ongoing investigation is underway to determine the full extent of the damage.